신경 복원·재생 시장에서 가장 큰 시술 유형은 무엇인가요?

신경 자극·신경조절 부문이 신경 복원·재생 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다.

신경 복원·재생 시장의 주요 최종 사용자 부문은 어디인가요?

병원 및 외래 수술 센터(ASC) 부문이 신경 복원·재생 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다.

아시아태평양 지역의 신경 복원·재생 시장 성장 전망은 어떤가요?

아시아태평양은 2026-2031년 동안 신경 복원 및 재생 시장에서 가장 빠른 성장이 예상되는 지역입니다.

신경 복원·재생 시장의 주요 기업은 어디인가요?

Medtronic plc, Boston Scientific Corporation, Axogen Corporation, Baxter, Integra LifeSciences Corporation, NeuroPace, Inc., Bioventus Inc., Abbott Laboratories, LivaNova PLC, Neuronetics, Inc. 등이 있습니다.

시장보고서

상품코드

2132777

신경 수복 및 재생 시장 예측(-2031년) : 제품별(신경조절 디바이스, 도관, 랩, 프로텍터, 이식편), 시술별(신경 수복[신경외, 신경 주위], 이식[동종 이식, 이종 이식]), 용도별, 최종사용자별, 디바이스 수별, 지역별

Nerve Repair & Regeneration Market by Product (Neuromodulation devices, Conduit, Wrap, Protector, Grafts), Procedure (Nerve Repair [Epineural, Perineural], Grafting [Allograft, Xenograft]), Application, End User, No. of Devices - Global Forecast to 2031

발행일: 2026년 09월 | 리서치사:

MarketsandMarkets | 페이지 정보: 영문 361 Pages | 배송안내 : 즉시배송

가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,950

￦ 6,799,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650

￦ 9,134,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 11,194,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 13,736,000

※ 부가세 별도

한글목차

영문목차

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신경 수복·재생 시장은 2026년 80억 6,000만 달러에서 2031년까지 126억 4,000만 달러로, CAGR 9.42%로 성장할 것으로 예측됩니다.

외상성 신경 손상, 말초신경 손상 및 신경질환의 발생률 증가가 효과적인 신경 복원 및 기능 회복 솔루션에 대한 수요를 견인하고 있습니다.

조사 범위
조사 대상 기간	2026-2031년
기준연도	2025년
예측 기간	2026-2031년
산정 단위	금액(10억 달러)
부문	제품별, 시술별, 용도별, 최종사용자별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

외과적 및 재생의학적 접근 방식이 지속적으로 발전함에 따라 병원 및 전문 의료 시설에서 혁신적인 신경 이식편, 신경 도관, 바이오소재 및 신경 자극 기술에 대한 수요가 확대되고 있습니다. 또한 조직 공학, 생체 공학 기반 스캐폴드, 신경 재생 기술 및 최소 침습 수술의 발전으로 치료 성과가 향상되고 기능 회복이 가속화되고 있습니다. 이러한 혁신을 통해 의료진은 복잡한 신경 손상을 보다 효과적으로 치료할 수 있게 되었으며, 이는 신경 복구 및 재생 시장의 성장을 지원하고 있습니다.

"시술 유형별로 보면 신경 자극 및 신경조절 부문이 신경 복원·재생 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다."

시술 유형별로 보면 신경 복원·재생 시장은 신경 자극·신경조절과 신경 복원·재생으로 구분됩니다. 신경 자극·신경조절 부문이 가장 큰 시장 점유율을 차지하는 이유는 만성 통증, 신경질환 및 신경 관련 질환의 관리에 있으며, 자극 요법이 확립되어 있기 때문입니다. 이러한 기술은 신경이나 신경 경로에 대한 전기 자극을 통해 표적화된 치료 개입을 제공함으로써 증상 관리와 환자 예후 개선을 지원합니다. 또한 이식형 및 비침습적 자극 시스템의 도입 확대, 첨단 신경조절 기술의 가용성 증대, 그리고 임상 적용 범위의 확대가 이러한 시술에 대한 수요를 지속적으로 지원하고 있으며, 신경 자극·신경조절은 시장 내에서 가장 큰 부문이 되었습니다.

"병원 및 외래 수술 센터(ASC) 부문은 신경 복원·재생 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다."

전 세계 신경 복원·재생 시장은 최종사용자별로 병원 및 외래 수술 센터(ASC), 전문 클리닉, 기타 최종사용자로 분류할 수 있습니다. 이 중 병원 및 ASC 부문이 가장 큰 시장 점유율을 차지했습니다. 병원 및 ASC는 전문 수술팀, 첨단 수술 시설, 포괄적인 수술 후 관리 체계가 갖춰져 있으며, 신경 복원, 재건 수술 및 신경 자극 요법의 주요 시행 장소로 자리매김하고 있습니다. 또한 전문적인 신경 치료법의 도입 확대, 첨단 수술 기기의 보급, 그리고 외래 수술에 대한 선호도 증가로 인해 전 세계 병원 및 ASC에서 신경 복원·재생 솔루션의 활용이 지속적으로 촉진될 것으로 예상됩니다.

"아시아태평양: 2026-2031년까지 신경 복원 및 재생 시장에서 가장 빠른 성장이 예상되는 지역"

전 세계 신경 복원·재생 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 구분됩니다. 아시아태평양은 2026-2031년에 지역별 가장 높은 연평균 성장률(CAGR)을 기록할 것으로 예측됩니다. 이 지역에서는 전문적인 의료 서비스와 외과수술 역량의 향상에 힘입어, 첨단 신경외과수술 및 재건 수술에 대한 수요가 증가하고 있습니다. 중국에서는 의료 인프라 확충과 전문 신경 의료에 대한 투자 확대를 통해 첨단 의료 기술에 대한 접근성이 확대되고 있습니다. 인도에서는 3차 의료 병원, 전문 클리닉, 외과 센터의 네트워크가 확대되고 있으며, 이는 신경 복원, 재생 및 신경조절 기술의 도입을 촉진하고 있습니다. 한편, 일본에서는 고령화의 진행과 신경질환·통증 관리 요법에 대한 수요 증가가 해당 지역 전체의 신경 복원·재생 시장 확대를 지속적으로 지원하고 있습니다.

Medtronic plc(아일랜드), Boston Scientific Corporation(영국), Axogen Corporation(영국), Baxter(영국), Integra LifeSciences Corporation(영국), NeuroPace, Inc.(영국), Bioventus Inc.(영국),Abbott Laboratories(영국), LivaNova PLC(영국), Neuronetics, Inc.(미국) 등이 신경 복원·재생 시장에서 사업을 운영하는 주요 기업입니다.

조사 범위:

본 조사 보고서에서는 신경 복원·재생 시장을 제품별(신경 자극·신경조절, 바이오소재 기반 제품), 시술별(신경 자극·신경조절, 신경 복원·재생),용도별(말초신경 손상, 척수 손상, 신경병성 통증, 신경퇴행성 질환, 뇌신경 장애, 비뇨기·골반 신경질환, 정형외과·스포츠 관련 신경 손상, 기타 용도),최종사용자별(병원·외래 수술 센터(ASC), 전문 클리닉, 기타 최종사용자) 및 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카)로 분류하고 있습니다.

이 보고서에서는 신경 복원·재생 시장의 성장에 영향을 미치는 주요 요인(촉진요인, 억제요인, 기회, 과제 등)에 대한 상세한 정보를 다루고 있습니다. 주요 업계 플레이어에 대한 상세한 분석을 통해 각 기업의 사업 개요, 솔루션, 인수, 계약, 제품 출시 등의 주요 전략 및 신경 복원·재생 시장의 최근 동향에 대한 인사이트를 제공합니다. 또한 이 보고서에서는 신경 복원·재생 시장 생태계에서 두각을 보이고 있는 신생 기업에 대한 경쟁 분석도 다루고 있습니다.

이 보고서를 구매해야 하는 이유:

이 보고서는 신경 복원 및 재생 시장 전체와 각 하위 부문의 매출에 대해 가장 정확한 추정치를 제공함으로써, 이 시장의 시장 리더와 신규 진입 기업을 지원합니다. 또한 이해관계자들이 경쟁 구도를 이해하고, 자사의 비즈니스를 더 나은 위치로 이끌며, 적절한 시장 진입 전략을 수립하는 데 필요한 인사이트를 얻는 데 도움이 됩니다. 더불어, 이 보고서는 이해관계자들이 시장 동향을 파악하는 데 도움을 주며, 주요 시장 촉진요인, 제약 요인, 기회 및 과제에 대한 정보를 제공합니다.

이 보고서는 다음 사항에 대한 인사이트를 제공합니다. :

주요 촉진요인(신경질환 및 신경 손상의 유병률 증가, 고령 인구 증가 및 이에 따른 신경질환 유병률 상승, 첨단 의료 인프라를 배경으로 한 정부별 지원 및 자금 제공, 첨단 신경조절 및 신경 자극 기술 개발) 및 제약 요인(신경조절 제품보다 약물 요법이 선호되는 경향),기회(신흥 경제국의 대규모 환자층 및 의료 투자 증가, 신경 복원·재생 기술의 임상 적용 범위 확대), 그리고 과제(신경 복원·재생 제품에 대한 엄격한 규제 체계와 시간이 오래 걸리는 승인 절차, 훈련된 전문가 부족) 등, 신경 복원·재생 시장의 성장에 영향을 미치는 요인에 대해 분석하고 있습니다
제품 개발/혁신: 신경 복원·재생 시장의 향후 기술, 연구개발 활동 및 신제품 출시에 대한 상세 인사이트
시장 개발: 수익성이 높은 시장에 대한 포괄적인 정보--이 보고서는 다양한 지역에 걸친 신경 복원·재생 시장을 분석하고 있습니다
시장 다각화: 신경 복원 및 재생 시장의 신제품, 미개발 지역, 최근 동향 및 투자에 관한 포괄적인 정보
경쟁 분석: Medtronic plc(아일랜드), Boston Scientific Corporation(미국), Axogen Corporation(미국), Baxter(미국), Integra LifeSciences Corporation(미국), NeuroPace, Inc.(미국), Bioventus Inc.(미국),Abbott Laboratories(미국), LivaNova PLC(영국), Neuronetics, Inc.(미국) 등 주요 기업의 시장 점유율, 성장 전략, 제품 라인업에 대한 상세한 평가

자주 묻는 질문

신경 수복·재생 시장의 규모는 어떻게 예측되나요?
- 2026년 80억 6,000만 달러에서 2031년까지 126억 4,000만 달러로 성장할 것으로 예측되며, CAGR은 9.42%로 전망됩니다.
신경 복원·재생 시장에서 가장 큰 시술 유형은 무엇인가요?
- 신경 자극·신경조절 부문이 신경 복원·재생 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다.
신경 복원·재생 시장의 주요 최종 사용자 부문은 어디인가요?
- 병원 및 외래 수술 센터(ASC) 부문이 신경 복원·재생 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다.
아시아태평양 지역의 신경 복원·재생 시장 성장 전망은 어떤가요?
- 아시아태평양은 2026-2031년 동안 신경 복원 및 재생 시장에서 가장 빠른 성장이 예상되는 지역입니다.
신경 복원·재생 시장의 주요 기업은 어디인가요?
- Medtronic plc, Boston Scientific Corporation, Axogen Corporation, Baxter, Integra LifeSciences Corporation, NeuroPace, Inc., Bioventus Inc., Abbott Laboratories, LivaNova PLC, Neuronetics, Inc. 등이 있습니다.

The nerve repair & regeneration market is projected to grow from USD 8.06 billion in 2026 to USD 12.64 billion by 2031, at a CAGR of 9.42%. The increasing incidence of traumatic nerve injuries, peripheral nerve damage, and neurological disorders is driving demand for effective nerve repair and functional restoration solutions.

Scope of the Report
Years Considered for the Study	2026-2031
Base Year	2025
Forecast Period	2026-2031
Units Considered	Value (USD billion)
Segments	Product, Procedure, Application, End User, Region
Regions covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

As surgical and regenerative approaches continue to advance, the need for innovative nerve grafts, conduits, biomaterials, and neurostimulation technologies is expanding across hospitals and specialty care settings. Furthermore, advancements in tissue engineering, bioengineered scaffolds, nerve regeneration techniques, and minimally invasive procedures are improving treatment outcomes and supporting faster functional recovery. These innovations enable healthcare providers to address complex nerve injuries more effectively, supporting growth in the nerve repair & regeneration market.

"The Neurostimulation and Neuromodulation segment is expected to account for the largest share of the nerve repair and regeneration market, by procedure."

Based on procedure, the nerve repair and regeneration market is segmented into neurostimulation & neuromodulation and nerve repair & regeneration. The neurostimulation & neuromodulation segment accounts for the largest market share because stimulation-based therapies are established for managing chronic pain, neurological disorders, and nerve-related conditions. These technologies provide targeted therapeutic interventions through electrical stimulation of nerves or neural pathways, supporting symptom management and improved patient outcomes. Additionally, the increasing adoption of implantable and non-invasive stimulation systems, growing availability of advanced neuromodulation technologies, and expanding clinical applications continue to support demand for these procedures, making neurostimulation and neuromodulation the largest segment within the market.

"The Hospitals and Ambulatory Surgical Centers segment is expected to account for the largest share of the nerve repair and regeneration market."

The global nerve repair and regeneration market can be segmented by end user into hospitals and ambulatory surgical centers (ASCs), specialty clinics, and other end users. Among these, the hospitals and ASCs segment accounted for the largest market share. Hospitals and ASCs remain the primary settings for nerve repair, reconstructive procedures, and neurostimulation interventions due to the availability of specialized surgical teams, advanced operating facilities, and comprehensive postoperative care. Furthermore, the increasing adoption of specialized nerve treatment procedures, the availability of advanced surgical equipment, and the growing preference for outpatient interventions are expected to support continued use of nerve repair and regeneration solutions across hospitals and ASCs worldwide.

"Asia Pacific: The fastest-growing market for nerve repair and regeneration from 2026 to 2031"

The global nerve repair and regeneration market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to grow at the highest regional CAGR from 2026 to 2031. The region is witnessing increasing demand for advanced neurological and reconstructive procedures, supported by improvements in specialized healthcare services and surgical capabilities. China is expanding access to advanced medical technologies through healthcare infrastructure development and increasing investments in specialized neurological care. India's growing network of tertiary-care hospitals, specialty clinics, and surgical centers is supporting the adoption of nerve repair, regeneration, and neuromodulation technologies. Meanwhile, Japan's aging population and increasing demand for neurological and pain management therapies continue to support the expansion of the nerve repair and regeneration market across the region.

The breakdown of the profile of primary participants in the nerve repair and regeneration market:

By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
By Designation: C-level Executives - 27%, Directors - 18%, and Others - 55%
By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa - 4%

Medtronic plc (Ireland), Boston Scientific Corporation (US), Axogen Corporation (US), Baxter (US), Integra LifeSciences Corporation (US), NeuroPace, Inc. (US), Bioventus Inc. (US), Abbott Laboratories (US), LivaNova PLC (UK), and Neuronetics, Inc. (US) are among the key players operating in the nerve repair and regeneration market.

Research Coverage:

This research report categorizes the nerve repair and regeneration market by product (neurostimulation & neuromodulation, biomaterial-based products), by procedure (neurostimulation & neuromodulation and nerve repair & regeneration), by application (peripheral nerve injuries, spinal cord injuries, neuropathic pain, neurodegenerative disorders, cranial nerve disorders, urological & pelvic nerve disorders, orthopedic & sports-related nerve injuries and other applications), by end user (hospitals & ASCs, specialty clinics, other end users), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa).

The report covers detailed information on major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the nerve repair and regeneration market. A detailed analysis of key industry players provides insights into their business overview, solutions, key strategies such as acquisitions, agreements, and product launches, and recent developments in the nerve repair and regeneration market. This report covers a competitive analysis of upcoming startups in the nerve repair and regeneration market ecosystem.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall repair and regeneration market and the subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (rising prevalence of neurological disorders and nerve injuries, rising geriatric population and the subsequent increase in the prevalence of neurological disorders, favorable government support and funding with advanced healthcare infrastructure, development of advanced neuromodulation and neurostimulation technologies), restraints (preference for drug therapies over neuromodulation products), opportunities (large patient population and rising healthcare investments in emerging economies, expanding clinical applications of nerve repair and regeneration technologies), and challenges (stringent regulatory framework and time-consuming approval processes for nerve repair and regeneration products, shortage of trained professionals) influencing the growth of the nerve repair and regeneration market
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the nerve repair and regeneration market
Market Development: Comprehensive information about lucrative markets-the report analyzes the nerve repair and regeneration market across varied regions
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the nerve repair and regeneration market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Medtronic plc (Ireland), Boston Scientific Corporation (US), Axogen Corporation (US), Baxter (US), Integra LifeSciences Corporation (US), NeuroPace, Inc. (US), Bioventus Inc. (US), Abbott Laboratories (US), LivaNova PLC (UK), and Neuronetics, Inc. (US)

TABLE 1 KEY MOVES & STRATEGIC FOCUS
TABLE 2 NERVE REPAIR & REGENERATION MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 3 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023-2030
TABLE 4 NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 5 EUROPE: MACROECONOMIC INDICATORS
TABLE 6 ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 7 LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 8 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
TABLE 9 NERVE REPAIR & REGENERATION MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 10 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY KEY PLAYER, 2024-2026 (USD)
TABLE 11 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY REGION, 2024-2026 (USD)
TABLE 12 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
TABLE 13 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
TABLE 14 NERVE REPAIR & REGENERATION MARKET: KEY CONFERENCES & EVENTS, 2026-2027
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 16 KEY PATENTS IN NERVE REPAIR & REGENERATION MARKET, 2022-2026
TABLE 17 KEY COMPANIES IMPLEMENTING AI IN NERVE REPAIR & REGENERATION MARKET
TABLE 18 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
TABLE 19 NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) MEDICAL DEVICES CLASSIFICATION
TABLE 20 JAPAN: CLASSIFICATION OF MEDICAL DEVICES
TABLE 21 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
TABLE 27 KEY BUYING CRITERIA, BY END USER
TABLE 28 ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 29 NERVE REPAIR & REGENERATION MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
TABLE 30 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 31 NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 32 SPINAL CORD STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 33 NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 34 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 35 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 36 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 37 DEEP BRAIN STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 38 NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 39 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 40 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 41 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 42 VAGUS NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 43 NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 44 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 45 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 46 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 47 SACRAL NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 48 NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 49 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 50 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 51 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 52 GASTRIC NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 53 NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 54 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 55 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 56 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 57 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 58 NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 59 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 60 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 61 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 62 TRANSCRANIAL MAGNETIC STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 63 NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 64 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 65 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 66 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 67 RESPIRATORY ELECTRICAL STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 68 NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 69 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 70 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 71 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 72 OTHER STIMULATION DEVICES OFFERED BY KEY PLAYERS
TABLE 73 NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 74 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 75 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 76 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 77 NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 78 NERVE CONDUITS OFFERED BY SOME MARKET PLAYERS
TABLE 79 NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY REGION, 2024-2031 (USD MILLION)
TABLE 80 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 81 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 82 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 83 NERVE GRAFTS OFFERED BY SOME MARKET PLAYERS
TABLE 84 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY REGION, 2024-2031 (USD MILLION)
TABLE 85 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 86 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 87 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 88 NERVE WRAPS OFFERED BY SOME MARKET PLAYERS
TABLE 89 NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY REGION, 2024-2031 (USD MILLION)
TABLE 90 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 91 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 92 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 93 NERVE PROTECTORS OFFERED BY SOME MARKET PLAYERS
TABLE 94 NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY REGION, 2024-2031 (USD MILLION)
TABLE 95 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 96 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 97 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 98 GLOBAL NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (NUMBER OF DEVICES)
TABLE 99 NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
TABLE 100 NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 101 NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
TABLE 102 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 103 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 104 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 105 NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
TABLE 106 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 107 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 108 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 109 NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 110 NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 111 NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
TABLE 112 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 113 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 114 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 115 NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
TABLE 116 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 117 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 118 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 119 NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
TABLE 120 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 121 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 122 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 123 NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
TABLE 124 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 125 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 126 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 127 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 128 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
TABLE 129 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 130 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 131 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 132 NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY REGION, 2024-2031 (USD MILLION)
TABLE 133 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 134 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 135 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 136 NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY REGION, 2024-2031 (USD MILLION)
TABLE 137 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 138 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 139 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 140 NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
TABLE 141 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 142 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 143 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 144 NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 145 NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 146 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 147 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 148 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 149 NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 150 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, 2024-2031 (USD MILLION)
TABLE 151 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 152 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 153 NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY REGION, 2024-2031 (USD MILLION)
TABLE 154 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 155 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 156 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 157 NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 158 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, 2024-2031 (USD MILLION)
TABLE 159 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 160 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 161 NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 162 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, 2024-2031 (USD MILLION)
TABLE 163 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 164 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 165 NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 166 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, 2024-2031 (USD MILLION)
TABLE 167 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 168 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 169 NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 170 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, 2024-2031 (USD MILLION)
TABLE 171 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 172 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 173 NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 174 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, 2024-2031 (USD MILLION)
TABLE 175 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 176 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 177 NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 178 NUMBER OF HOSPITALS PER CAPITA, BY COUNTRY, 2026
TABLE 179 NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 180 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 181 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 182 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 183 NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY REGION, 2024-2031 (USD MILLION)
TABLE 184 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 185 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 186 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 187 NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 188 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, 2024-2031 (USD MILLION)
TABLE 189 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 190 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 191 NERVE REPAIR & REGENERATION MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 192 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 193 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 194 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 195 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 196 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
TABLE 197 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 198 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 199 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 200 NORTH AMERICA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 201 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 202 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 203 COMPANY PRODUCTS THAT RECEIVED APPROVAL IN US
TABLE 204 US: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 205 US: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 206 US: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 207 US: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
TABLE 208 US: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 209 US: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 210 US: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 211 US: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 212 US: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 213 US: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)